| Patents for A61P 25 - Drugs for disorders of the nervous system (183,225) |
|---|
| 05/17/2007 | US20070112046 2'-Methyl-5'-(1,3,4-Oxadiazol-2-yl)-1,1'-Biphenyl-4-Carboxamide Derivatives and Their Use As P38 Kinase Inhibitors |
| 05/17/2007 | US20070112043 Acylated and non-acylated imidazo[2,1-b]-1,3,4,-thiadiazole-2-sulfonamides, and uses thereof |
| 05/17/2007 | US20070112029 Piperidine compound and process for preparing the same |
| 05/17/2007 | US20070112025 Use of kynurenine-3-hydroxylase inhibitors for the preparation of medicaments for the treatment of l-dopa induced movement disorders, dyskinesias, drug addiction, pain and cataract |
| 05/17/2007 | US20070111945 Use of corticotroph-derived glycoprotein hormone to treat inflammation and potentiate glucocorticoid action |
| 05/17/2007 | US20070111942 For detecting ligands that stimulate the proliferation and/or development of hematopoietic, lymphoid and myeloid cells |
| 05/17/2007 | US20070110835 Method for the production of enriched hop extracts having combined oestrogenic and antiproliferative bioactivity |
| 05/17/2007 | US20070110821 Use of xenon for treating neurointoxications |
| 05/17/2007 | US20070110730 Multipotent stem cells from peripheral tissues and uses thereof |
| 05/16/2007 | EP1785425A2 Novel 1,4-diazabicycloalkane derivatives, their preparation and use |
| 05/16/2007 | EP1785138A1 Mitochondria activators |
| 05/16/2007 | EP1785134A2 Thiazole, imidazole and oxazole compounds and treatments of disorders associated with protein aging |
| 05/16/2007 | EP1784409A2 Substituted thienopyrrole carboxylic acid amides, pyrrolothiazole carboxylic acid amides, and related analogs as inhibitors of casein kinase i epsilon |
| 05/16/2007 | EP1784400A1 Histamine h3 receptor agents, preparation and therapeutic uses |
| 05/16/2007 | EP1784394A1 Novel piperidine derivatives as histamine h3 receptor ligands for treatment of depression |
| 05/16/2007 | EP1784393A1 Quinazolines useful as modulators of ion channels |
| 05/16/2007 | EP1784381A1 Novel substituted aryloxy alkylamines and their use as monoamine neurotransmitter re-uptake inhibitors |
| 05/16/2007 | EP1784218A1 Nutricional composition comprising immunoglobulins and oligosaccharides |
| 05/16/2007 | EP1784195A1 Pharmaceutical composition comprising galactose, selenium, vitamin e and/or phosphatidyl choline, and pharmaceutical uses of galactose |
| 05/16/2007 | EP1784191A1 Treatment of psychological and cognitive disorders using a cholesterol-lowering agent in combination with an antidepressant |
| 05/16/2007 | EP1784184A2 The use of n-aryl diazaspiracyclic compounds in the treatment of addiction |
| 05/16/2007 | EP1784178A1 Aryl (or heteroaryl) azolylcarbinols |
| 05/16/2007 | EP1784177A2 Novel formulation for l-tryptophane comprising carbidopa/benserazide |
| 05/16/2007 | EP1587788B1 2,7-substituted indoles and their use as 5-ht6 modulators |
| 05/16/2007 | EP1534712B1 Pyrazolo[1,5-a]pyrimidine compounds as cyclin dependent kinase inhibitors |
| 05/16/2007 | EP1448544B1 Substituted benzopyrans as selective estrogen receptor-beta agonists |
| 05/16/2007 | EP1306373B1 3,4-dihydroisoquinoline derivative compounds and drugs containing these compounds as the active ingredient |
| 05/16/2007 | EP1305285B1 N-substituted indoles useful in the treatment of diabetes |
| 05/16/2007 | EP1265900B1 1,5-disubstituted-3,4-dihydro-1h-pyrimido 4,5-d|pyrimidin-2-one compounds and their use in treating csbp/p38 kinase mediated diseases |
| 05/16/2007 | EP1203019B1 Peptides containing n-substituted l-amino acids for preventing beta-strand association |
| 05/16/2007 | EP1115405B1 Use of tnf-alpha inhibitors for treating nerve root injury |
| 05/16/2007 | EP1085896B1 Conformationally constrained backbone cyclized somatostatin analogs |
| 05/16/2007 | EP0789567B1 A method for treating vascular headaches |
| 05/16/2007 | DE202006018609U1 Verwendung von Opioidformulierungen in nadellosen Vorrichtungen zur Medikamentenverabreichung Use of opioid formulations needleless devices for drug delivery |
| 05/16/2007 | CN1964973A Pyrrazolo-pyrimidine derivatives |
| 05/16/2007 | CN1964968A 1-aza-bicyclo[3.3.1]nonanes |
| 05/16/2007 | CN1964958A Novel alkyl substituted piperazine derivatives used as monoamine neurotransmitter re-uptake inhibitors |
| 05/16/2007 | CN1964956A Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1 |
| 05/16/2007 | CN1964948A Therapeutic agents |
| 05/16/2007 | CN1964741A Methods of using molecules related to organic cation transporter 3 (OCT3) for treating depression, anxiety neuroses, drug dependencies, and other similar mental disorders |
| 05/16/2007 | CN1964709A Memory fixation accelerator |
| 05/16/2007 | CN1964708A Novel use of peptide compounds for treating pain in trigeminal neuralgia |
| 05/16/2007 | CN1964703A Immediate release pharmaceutical tablets with height greater than width |
| 05/16/2007 | CN1962641A Metalloproteinase inhibitors |
| 05/16/2007 | CN1962612A Novel pregabalin crystal form and preparing method thereof |
| 05/16/2007 | CN1962596A Ketone compounds and compositions for cholesterol management and related uses |
| 05/16/2007 | CN1961951A Chinese medicinal formulation for treating hydrocephalus |
| 05/16/2007 | CN1961947A Chinese medicine capable of treating depression and beautifying face and preparation method thereof |
| 05/16/2007 | CN1961928A Blood circulation-activating stasis-removing medicament for treating blood stasis syndrome and preparation process thereof |
| 05/16/2007 | CN1961889A Application of isoliquiritigenin in preparation of medicament for preventing and/or treating depression |
| 05/16/2007 | CN1961879A Pharmaceutical composition for nose administered in-situ gel spray of Huperzine A, preparation process and use thereof |
| 05/16/2007 | CN1961877A Pharmaceutical composition for treating withdrawal syndrome |
| 05/16/2007 | CN1961872A Use of choline in preparation of medicament having central or peripheral pain easing function |
| 05/16/2007 | CN1961701A Anti-sleepy tri-taste sugar |
| 05/16/2007 | CN1315862C Methods and compositions for treating flaviviruses and pestiviruses |
| 05/16/2007 | CN1315847C 1-thia-3-aza-dibenzoazulenes as inhibitors of tumour necrosis factor production and intermediates for the preparation thereof |
| 05/16/2007 | CN1315840C Substituted 1-oxa-2,8-diaza-spiro[4,5]dec-2-ene derivatives used as drug for treating pain |
| 05/16/2007 | CN1315835C Polycyclic guanine phosphodiesterase v inhibitors |
| 05/16/2007 | CN1315833C Azaindole kinase inhibitors |
| 05/16/2007 | CN1315832C Heteroaryl substituted 2-pyridinyl and 2-pyrimidinyl-6,7,8,9-tetrahydropydimido[1,2-a]pyrimidin-4-one derivatives |
| 05/16/2007 | CN1315827C 1-(aminoalkyl)-3-sulfonylazaindoles as 5-hydroxytryptamine-6 ligands |
| 05/16/2007 | CN1315826C Process for preparing 3-(2-(4-(6-fluorobenzo(d) isoxazol-3-yl)-piperidin-1yl)-ethyl)-2-methyl-6,7,8,9-tetrahydro-4h-pyrido-(1,2-a) pyrimidin-4-one |
| 05/16/2007 | CN1315813C 2-amino-4h-3,1-benzoxazin-4-one derivatives for the treatment of obesity |
| 05/16/2007 | CN1315809C Quinoline derivatives and their use as 5-HT6 ligands |
| 05/16/2007 | CN1315517C Sucking tablet of gastrodia elata and its production method |
| 05/16/2007 | CN1315507C Externally applied ointment |
| 05/16/2007 | CN1315497C Effective place of polygala root and its use |
| 05/16/2007 | CN1315494C Traditional Chinese medicine prepn. for treating mental disease |
| 05/16/2007 | CN1315473C Therapeutic compositions |
| 05/16/2007 | CN1315464C Wild aconite drip pill for treating cancer pain and its preparation method |
| 05/16/2007 | CN1315458C Compound tall gastrodia tuber preparation and production thereof |
| 05/15/2007 | USRE39634 treatment of neuropathic pain; elevate levels of anandamide or other endogenous cannabinoids to increase the nociceptive threshold |
| 05/15/2007 | US7217840 Method for preparing 1,3,5-triaminobenzene and hydrolyzing it into high-purity phloroglucinal |
| 05/15/2007 | US7217826 Making intermediates to alpha-ethyl-2-oxo-1-pyrrolidine acetamide, also referred to as levetiracetam an antihypoxic agent and antiischemic agent; by reduction via catalytic hydrogenation of an alkenyl intermediate |
| 05/15/2007 | US7217738 β2-adrenergic receptor agonists |
| 05/15/2007 | US7217734 Substituted benzopyrans as selective estrogen receptor-beta agonists |
| 05/15/2007 | US7217732 Cannabinoid receptor agonists |
| 05/15/2007 | US7217729 4,6-Dimethyl-3-{[3'-(N,N-dimethylaminomethyl)-4-hydroxy-4'-(3''-methoxyphenyl)-cyclohexylamino]-methyl}-1H-indole 2-carboxylic acid ethyl ester or other derivatives of substituted indoles; for treatment or prevention of neurodegenerative diseases, psychological disorders, AIDS, inflammation or allergies |
| 05/15/2007 | US7217728 For therapy of reperfusion injury |
| 05/15/2007 | US7217724 2-[(2-hydroxy-2-pyridinylethyl)amino]ethyl-substituted indoles, e.g., N,N-Diethyl-2-{3-[(2R)-2-((2R)-2-hydroxy-2-pyridin-3-ylethylamino)-propyl]-1H-indol-7-yloxy}acetamide; beta 3-adrenoceptor stimulants, used for treating obesity, hyperglycemia, frequent urination, and urinary incontinence |
| 05/15/2007 | US7217719 1,3,8-Triaza-spiro[4.5]decan-2-one compounds, e.g., (4S)/(4R)-4-(4-Fluorobenzyl)-3-(4-isobutoxybenzyl)-8-methyl-1,3,8-triaza-spiro [4.5]decan-2-one; treating schizophrenia, psychosis, migraine, hypertension, thrombosis, vasospasm, depression, anxiety, sleep and eating disorders |
| 05/15/2007 | US7217716 Such as 4-((methyl-pyrimidin-2-ylamino)-methyl)-piperidine-1-carboxylic acid benzyl ester; useful for pain relief; treating migraine, depression, anxiety, schizophrenia, Parkinson's disease, and stroke; N-methyl-D-aspartate NR2B antagonists |
| 05/15/2007 | US7217705 synergistic effect; CB1 receptor antagonist is an azetidine compound of given formula such as N-{1-[bis(4-chlorophenyl)methyl]azetidin-3-yl}-N-(3,5-difluorophenyl)methylsulfonamide, and the dopaminergic agent is ropinirole or levodopa for example |
| 05/15/2007 | US7217702 Adenine derivatives, especially substituted with an alkynylene-, alkenylene-, alkadienylene- or alkynylenealkenylene- group; e.g., 2-{3-[1-(Methoxycarbanoyl)piperidin-4-yl]propyn-1-yl}-9-propargyladenine; stimulating motor activity without dyskinesia; treating Huntington's & Parkinson's diseases, etc. |
| 05/15/2007 | US7217701 Intracellular calcium concentration increase inhibitors |
| 05/15/2007 | US7217698 Tetraacylated N-cyclopropylcarbonylmannosamines; treating Alzheimer's and Parkinson's disease |
| 05/15/2007 | US7217694 Inhibitors of IAPP fibril formation and uses thereof |
| 05/15/2007 | US7217687 Use of osteopontin for the treatment and/or prevention of neurologic diseases |
| 05/15/2007 | US7217565 Contacting, binding to monoclonal antibodies; therapy for central nervous system disorders |
| 05/15/2007 | US7217555 isolated human NAALAD-ase (N-acetylated alpha-linked acidic dipeptidases) L protein; |
| 05/15/2007 | US7217534 Methods of screening apoptosis modulating compounds, compounds identified by said methods and use of said compounds as therapeutic agents |
| 05/15/2007 | CA2392973C Benzoimidazole derivatives useful as antiproliferative agents |
| 05/15/2007 | CA2366829C Novel morpholine derivatives, method for the production thereof and pharmaceutical preparations containing said derivatives |
| 05/15/2007 | CA2325739C Combination for the treatment of alcohol and drug dependence containing an opioid antagonist and a nmda receptor complex modulator |
| 05/15/2007 | CA2268455C Methods and apparatus for treatment of parkinson's disease |
| 05/15/2007 | CA2176948C Chaperonin 10 |
| 05/15/2007 | CA2155275C Aminoalkyloximes, a process for their preparation, their use as medicaments and intermediate compounds |
| 05/10/2007 | WO2007053618A1 Prodrugs of muscarinic agonists and methods of treatment of neuropsychiatric disorders |
| 05/10/2007 | WO2007053596A1 Gaba receptor mediated modulation of neurogenesis |
| 05/10/2007 | WO2007053353A2 Pyrrolo[2,3-f] and [3,2-f]isoquinolinone derivatives as 5-hydroxytryptamine-6 ligands |